Seres Therapeutics

MCRB · NASDAQ

$2.31−$0.11 (−4.55%)TodayMarket closed ·
Prev close $2.42

Who owns MCRB

Largest institutional holders, from their latest 13F filings

The 10 largest institutions hold 32.6% of MCRB’s shares.

  • Flagship Ventures11.9%
  • Nestle SA11.3%
  • Vanguard Capital Management, LLC3.0%
  • Marshall Wace LLP1.8%
  • Next 6 largest institutions4.7%
  • All other shareholders67.4%
Top institutional holders of MCRB
HolderShares% of shares
Flagship Ventures1.16M11.94%
Nestle SA1.09M11.25%
Vanguard Capital Management, LLC287.78K2.97%
Marshall Wace LLP172.25K1.78%
Bank Vontobel AG122.97K1.27%
BlackRock Institutional Trust Company, N.A.109.30K1.13%
Geode Capital Management, L.L.C.79.97K0.83%
Susquehanna International Group, LLP58.33K0.60%
Vanguard Fiduciary Trust Co48.69K0.50%
State Street Investment Management (US)33.90K0.35%

Largest mutual fund holders

Top mutual fund holders of MCRB
HolderShares% of shares
Vanguard Total Stock Market Index Fund206.17K2.13%
Vanguard Extended Market Index Fund75.85K0.78%
Fidelity Extended Market Index Fund36.63K0.38%
Schwab U.S. Small-Cap ETF30.83K0.32%
iShares Micro-Cap ETF25.72K0.27%

Insider trades

Form 4 filings by officers, directors and large holders

Over the last 6 months, insiders sold $5.80K (8 trades) of MCRB on the open market, with no buys.

Latest MCRB insider transactions
InsiderTypeSharesValue
Brady KellySale64$291
Shaff Eric D.Sale263$1.20K
Henn Matthew RSale81$369
DesRosier ThomasSale82$373
Brady KellyOption exercise91—
Brady KellyOption exercise90—
Brady KellyOption exercise181—
Shaff Eric D.Option exercise332—
Shaff Eric D.Option exercise390—
Shaff Eric D.Option exercise722—

Short interest

Settled Sep 30, 2026

Shares short
314.26K
Days to cover
5.15
% of shares outstanding
3.25%
Average daily volume
61.07K
Change since last report
+4.3%

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.